OTLKW and OTLK Related Headlines

Go Back

Apr 22, 2026 08:30AM Outlook Therapeutics raises $5 million in registered direct offering

Apr 22, 2026 08:30AM Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Apr 7, 2026 08:50AM Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA

Dec 26, 2025 05:00PM Outlook Therapeutics Announces New Employment Inducement Grants

OTLKW and OTLK Related Press Releases

Go Back

Apr 22, 2026 08:30AM Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Apr 7, 2026 08:50AM Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA

Dec 26, 2025 05:00PM Outlook Therapeutics Announces New Employment Inducement Grants

OTLKW and OTLK Related SEC Filings

Go Back